vimarsana.com
Home
Live Updates
Zai Lab Announces the First Listing of VYVGART® (efgart
Zai Lab Announces the First Listing of VYVGART® (efgart
Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China's National Reimbursement Drug List | Business
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 12, 2023--
Related Keywords
China ,
Hong Kong ,
Massachusetts ,
United States ,
Taiwan ,
Macau ,
Shanghai ,
William Liang ,
Josh Smiley ,
Christine Chiou Lina Zhang ,
Shaun Maccoun Xiaoyu Chen ,
Zai Lab Limited ,
China National Healthcare Security Administration ,
Glaxosmithkline ,
Exchange Commission ,
Zai Lab Forward ,
National Reimbursement Drug List ,
Zai Lab ,
Paratek Pharmaceuticals Inc ,
National Medical Products Administration ,
Lab Limited ,
Reimbursement Drug List ,
National Healthcare Security Administration ,
Chief Commercial Officer ,
Chief Operating Officer ,
Myasthenia Gravis ,
Greater China ,
Paratek Pharmaceuticals ,
Ovarian Cancer ,
Private Securities Litigation Reform Act ,
Investor Relations ,
Business Wire ,
Business ,